Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Oct;24(10):1331-1333.
doi: 10.1111/1756-185X.14214. Epub 2021 Sep 14.

What are the benefits and harms of belimumab for patients with systemic lupus erythematosus?: A Cochrane Review summary with commentary

Giovanni Iolascon  1
Affiliations
Comment

What are the benefits and harms of belimumab for patients with systemic lupus erythematosus?: A Cochrane Review summary with commentary

Giovanni Iolascon. Int J Rheum Dis. 2021 Oct.
No abstract available

Keywords: Cochrane Review summary; belimumab; systemic lupus erythematosus.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflicts of interest.

Figures

None
http://rehabilitation.cochrane.org
See this image and copyright information in PMC

Comment on

  • Belimumab for systemic lupus erythematosus.
    Singh JA, Shah NP, Mudano AS. Singh JA, et al. Cochrane Database Syst Rev. 2021 Feb 25;2(2):CD010668. doi: 10.1002/14651858.CD010668.pub2. Cochrane Database Syst Rev. 2021. PMID: 33631841 Free PMC article.

References

    1. Singh JA, Shah NP, Mudano AS. 10.1002/14651858.CD010668.pub2. Cochrane Database Syst Rev. 2021;2(2):CD010668. 10.1002/14651858.CD010668.pub2 - DOI - DOI - PMC - PubMed
    1. Justiz Vaillant AA, Goyal A, Bansal P, et al. Systemic Lupus Erythematosus. [Updated 2020 Dec 30]. In: StatPearls [Internet]. StatPearls Publishing; 2021 Jan‐. https://www.ncbi.nlm.nih.gov/books/NBK535405/ - PubMed
    1. Kiriakidou M, Ching CL. Systemic lupus erythematosus. Ann Intern Med. 2020;172(11):ITC81‐ITC96. 10.7326/AITC202006020 - DOI - PubMed
    1. Fanouriakis A, Kostopoulou M, Alunno A, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736‐745. 10.1136/annrheumdis-2019-215089 - DOI - PubMed
    1. Parodis I, Axelsson M, Gunnarsson I. Belimumab for systemic lupus erythematosus: a practice‐based view. Lupus. 2013;22(4):372‐380. 10.1177/0961203313476154 - DOI - PubMed

MeSH terms

Substances